{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T06:20:57Z","timestamp":1773469257955,"version":"3.50.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2016,4,22]],"date-time":"2016-04-22T00:00:00Z","timestamp":1461283200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100008792","name":"Novartis Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008792","id-type":"DOI","asserted-by":"publisher"}]},{"name":"STZ OcuTox Preclinical Drug Assessment"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1007\/s00417-016-3344-8","type":"journal-article","created":{"date-parts":[[2016,4,22]],"date-time":"2016-04-22T04:19:56Z","timestamp":1461298796000},"page":"1117-1125","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The effects of VEGF-A-inhibitors aflibercept and ranibizumab on the ciliary body and iris of monkeys"],"prefix":"10.1007","volume":"254","author":[{"given":"Maximilian","family":"Ludinsky","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Christner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nan","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatjana","family":"Taubitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Tschulakow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antje","family":"Biesemeier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvie","family":"Julien-Schraermeyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrich","family":"Schraermeyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,4,22]]},"reference":[{"key":"3344_CR1","doi-asserted-by":"crossref","unstructured":"Tah V, Orlans HO, Hyer J, Casswell E, Din N, Sri Shanmuganathan V, Ramskold L, Pasu S (2015) Anti-VEGF therapy and the retina: an update. J Ophthalmol: 627674. doi 10.1155\/2015\/627674","DOI":"10.1155\/2015\/627674"},{"key":"3344_CR2","first-page":"50","volume":"128","author":"MM Bikbov","year":"2012","unstructured":"Bikbov MM, Babushkin AE, Orenburkina OI (2012) Anti-VEGF-agents in treatment of neovascular glaucoma. Vestn Oftalmol 128:50\u201353","journal-title":"Vestn Oftalmol"},{"key":"3344_CR3","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ajo.2006.02.045","volume":"142","author":"S Grisanti","year":"2006","unstructured":"Grisanti S, Biester S, Peters S, Tatar O, Ziemssen F, Bartz-Schmidt KU, Tuebingen Bevacizumab Study G (2006) Intracameral bevacizumab for iris rubeosis. Am J Ophthalmol 142:158\u2013160. doi: 10.1016\/j.ajo.2006.02.045","journal-title":"Am J Ophthalmol"},{"key":"3344_CR4","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.survophthal.2010.08.006","volume":"56","author":"M Tolentino","year":"2011","unstructured":"Tolentino M (2011) Systemic and ocular safety of intravitreal anti-VEGF therapies for ocular neovascular disease. Surv Ophthalmol 56:95\u2013113. doi: 10.1016\/j.survophthal.2010.08.006","journal-title":"Surv Ophthalmol"},{"key":"3344_CR5","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1080\/09273940802596534","volume":"17","author":"AJ Barkmeier","year":"2009","unstructured":"Barkmeier AJ, Akduman L (2009) Bevacizumab (Avastin) in ocular processes other than choroidal neovascularization. Ocul Immunol Inflamm 17:109\u2013117. doi: 10.1080\/09273940802596534","journal-title":"Ocul Immunol Inflamm"},{"key":"3344_CR6","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1002\/phar.1264","volume":"33","author":"LK Cheung","year":"2013","unstructured":"Cheung LK, Eaton A (2013) Age-related macular degeneration. Pharmacotherapy 33:838\u2013855. doi: 10.1002\/phar.1264","journal-title":"Pharmacotherapy"},{"key":"3344_CR7","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.ajo.2007.03.007","volume":"143","author":"S Peters","year":"2007","unstructured":"Peters S, Heiduschka P, Julien S, Ziemssen F, Fietz H, Bartz-Schmidt KU, Tubingen Bevacizumab Study G, Schraermeyer U (2007) Ultrastructural findings in the primate eye after intravitreal injection of bevacizumab. Am J Ophthalmol 143:995\u20131002. doi: 10.1016\/j.ajo.2007.03.007","journal-title":"Am J Ophthalmol"},{"key":"3344_CR8","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1136\/bjophthalmol-2013-304019","volume":"98","author":"S Julien","year":"2014","unstructured":"Julien S, Biesemeier A, Taubitz T, Schraermeyer U (2014) Different effects of intravitreally injected ranibizumab and aflibercept on retinal and choroidal tissues of monkey eyes. Br J Ophthalmol 98:813\u2013825. doi: 10.1136\/bjophthalmol-2013-304019","journal-title":"Br J Ophthalmol"},{"key":"3344_CR9","doi-asserted-by":"crossref","first-page":"9478","DOI":"10.1167\/iovs.11-8353","volume":"52","author":"KM Ford","year":"2011","unstructured":"Ford KM, Saint-Geniez M, Walshe T, Zahr A, D\u2019Amore PA (2011) Expression and role of VEGF in the adult retinal pigment epithelium. Invest Ophthalmol Vis Sci 52:9478\u20139487. doi: 10.1167\/iovs.11-8353","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3344_CR10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF02720789","volume":"1","author":"H Helmholtz","year":"1855","unstructured":"Helmholtz H (1855) Ueber die Accommodation des Auges. Graefes Arch Clin Exp Ophthalmol 1:1\u201374. doi: 10.1007\/BF02720789","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"3344_CR11","unstructured":"Welsch U, Deller T (2010) Lehrbuch Histologie. Urban & Fischer Verlag\/Elsevier, Munich, pp 210, 504"},{"key":"3344_CR12","doi-asserted-by":"crossref","first-page":"7520","DOI":"10.1167\/iovs.12-10098","volume":"53","author":"KM Ford","year":"2012","unstructured":"Ford KM, Saint-Geniez M, Walshe TE, D\u2019Amore PA (2012) Expression and role of VEGF--a in the ciliary body. Invest Ophthalmol Vis Sci 53:7520\u20137527. doi: 10.1167\/iovs.12-10098","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3344_CR13","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.yexcr.2005.11.012","volume":"312","author":"M Shibuya","year":"2006","unstructured":"Shibuya M, Claesson-Welsh L (2006) Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis. Exp Cell Res 312:549\u2013560. doi: 10.1016\/j.yexcr.2005.11.012","journal-title":"Exp Cell Res"},{"key":"3344_CR14","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1161\/ATVBAHA.108.179663","volume":"29","author":"N Ferrara","year":"2009","unstructured":"Ferrara N (2009) Vascular endothelial growth factor. Arterioscler Thromb Vasc Biol 29:789\u2013791. doi: 10.1161\/ATVBAHA.108.179663","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"3344_CR15","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s10384-008-0580-4","volume":"52","author":"S Wolf","year":"2008","unstructured":"Wolf S (2008) Current status of anti-vascular endothelial growth factor therapy in Europe. Jpn J Ophthalmol 52:433\u2013439. doi: 10.1007\/s10384-008-0580-4","journal-title":"Jpn J Ophthalmol"},{"key":"3344_CR16","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1136\/bjo.81.6.501","volume":"81","author":"RO Schlingemann","year":"1997","unstructured":"Schlingemann RO, van Hinsbergh VW (1997) Role of vascular permeability factor\/vascular endothelial growth factor in eye disease. Br J Ophthalmol 81:501\u2013512","journal-title":"Br J Ophthalmol"},{"key":"3344_CR17","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1517\/14712598.2012.748741","volume":"13","author":"U Schraermeyer","year":"2013","unstructured":"Schraermeyer U, Julien S (2013) Effects of bevacizumab in retina and choroid after intravitreal injection into monkey eyes. Expert Opin Biol Ther 13:157\u2013167. doi: 10.1517\/14712598.2012.748741","journal-title":"Expert Opin Biol Ther"},{"key":"3344_CR18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0113701","volume":"9","author":"A Tschulakow","year":"2014","unstructured":"Tschulakow A, Christner S, Julien S, Ludinsky M, van der Giet M, Schraermeyer U (2014) Effects of a single intravitreal injection of aflibercept and ranibizumab on glomeruli of monkeys. PLoS One 9, e113701. doi: 10.1371\/journal.pone.0113701","journal-title":"PLoS One"},{"key":"3344_CR19","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1056\/NEJM197108122850711","volume":"285","author":"J Folkman","year":"1971","unstructured":"Folkman J (1971) Tumor angiogenesis: therapeutic implications. N Engl J Med 285:1182\u20131186. doi: 10.1056\/NEJM197111182852108","journal-title":"N Engl J Med"},{"key":"3344_CR20","first-page":"4","volume":"61","author":"J Folkman","year":"1992","unstructured":"Folkman J (1992) Angiogenesis\u2014retrospect and outlook. EXS 61:4\u201313","journal-title":"EXS"},{"key":"3344_CR21","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1056\/NEJM200002173420707","volume":"342","author":"SL Fine","year":"2000","unstructured":"Fine SL, Berger JW, Maguire MG, Ho AC (2000) Age-related macular degeneration. N Engl J Med 342:483\u2013492. doi: 10.1056\/NEJM200002173420707","journal-title":"N Engl J Med"},{"key":"3344_CR22","first-page":"343","volume":"15","author":"DH Nguyen","year":"2013","unstructured":"Nguyen DH, Luo J, Zhang K, Zhang M (2013) Current therapeutic approaches in neovascular age-related macular degeneration. Discov Med 15:343\u2013348","journal-title":"Discov Med"},{"key":"3344_CR23","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1136\/bjo.2007.133496","volume":"92","author":"S Peters","year":"2008","unstructured":"Peters S, Heiduschka P, Julien S, Bartz-Schmidt KU, Schraermeyer U (2008) Immunohistochemical localisation of intravitreally injected bevacizumab in the anterior chamber angle, iris and ciliary body of the primate eye. Br J Ophthalmol 92:541\u2013544. doi: 10.1136\/bjo.2007.133496","journal-title":"Br J Ophthalmol"},{"key":"3344_CR24","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/IJG.0b013e3180457c47","volume":"16","author":"S Yazdani","year":"2007","unstructured":"Yazdani S, Hendi K, Pakravan M (2007) Intravitreal bevacizumab (Avastin) injection for neovascular glaucoma. J Glaucoma 16:437\u2013439. doi: 10.1097\/IJG.0b013e3180457c47","journal-title":"J Glaucoma"},{"key":"3344_CR25","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1159\/000327364","volume":"226","author":"A Wolf","year":"2011","unstructured":"Wolf A, von Jagow B, Ulbig M, Haritoglou C (2011) Intracameral injection of bevacizumab for the treatment of neovascular glaucoma. Ophthalmologica 226:51\u201356. doi: 10.1159\/000327364","journal-title":"Ophthalmologica"},{"key":"3344_CR26","doi-asserted-by":"crossref","first-page":"75","DOI":"10.4103\/0974-9233.53865","volume":"16","author":"AA Ghanem","year":"2009","unstructured":"Ghanem AA, El-Kannishy AM, El-Wehidy AS, El-Agamy AF (2009) Intravitreal bevacizumab (avastin) as an adjuvant treatment in cases of neovascular glaucoma. Middle East African J Ophthalmol 16:75\u201379. doi: 10.4103\/0974-9233.53865","journal-title":"Middle East African J Ophthalmol"},{"key":"3344_CR27","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1007\/s00417-013-2428-y","volume":"251","author":"J Luke","year":"2013","unstructured":"Luke J, Nassar K, Luke M, Grisanti S (2013) Ranibizumab as adjuvant in the treatment of rubeosis iridis and neovascular glaucoma\u2014results from a prospective interventional case series. Graefes Arch Clin Exp Ophthalmol 251:2403\u20132413. doi: 10.1007\/s00417-013-2428-y","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"3344_CR28","doi-asserted-by":"crossref","first-page":"161","DOI":"10.4103\/0974-620X.106099","volume":"5","author":"Y Tu","year":"2012","unstructured":"Tu Y, Fay C, Guo S, Zarbin MA, Marcus E, Bhagat N (2012) Ranibizumab in patients with dense cataract and proliferative diabetic retinopathy with rubeosis. Oman J Ophthalmol 5:161\u2013165. doi: 10.4103\/0974-620X.106099","journal-title":"Oman J Ophthalmol"},{"key":"3344_CR29","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1083\/jcb.140.4.947","volume":"140","author":"S Esser","year":"1998","unstructured":"Esser S, Wolburg K, Wolburg H, Breier G, Kurzchalia T, Risau W (1998) Vascular endothelial growth factor induces endothelial fenestrations in vitro. J Cell Biol 140:947\u2013959","journal-title":"J Cell Biol"},{"issue":"Pt 6","key":"3344_CR30","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1242\/jcs.108.6.2369","volume":"108","author":"WG Roberts","year":"1995","unstructured":"Roberts WG, Palade GE (1995) Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. J Cell Sci 108(Pt 6):2369\u20132379","journal-title":"J Cell Sci"},{"key":"3344_CR31","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0002-9440(10)63273-7","volume":"165","author":"T Inai","year":"2004","unstructured":"Inai T, Mancuso M, Hashizume H, Baffert F, Haskell A, Baluk P, Hu-Lowe DD, Shalinsky DR, Thurston G, Yancopoulos GD, McDonald DM (2004) Inhibition of vascular endothelial growth factor (VEGF) signaling in cancer causes loss of endothelial fenestrations, regression of tumor vessels, and appearance of basement membrane ghosts. Am J Pathol 165:35\u201352. doi: 10.1016\/S0002-9440(10)63273-7","journal-title":"Am J Pathol"},{"key":"3344_CR32","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.preteyeres.2013.07.003","volume":"37","author":"D Ardeljan","year":"2013","unstructured":"Ardeljan D, Chan CC (2013) Aging is not a disease: distinguishing age-related macular degeneration from aging. Prog Retin Eye Res 37:68\u201389. doi: 10.1016\/j.preteyeres.2013.07.003","journal-title":"Prog Retin Eye Res"},{"key":"3344_CR33","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1136\/pgmj.2005.040857","volume":"82","author":"SM Salvi","year":"2006","unstructured":"Salvi SM, Akhtar S, Currie Z (2006) Ageing changes in the eye. Postgrad Med J 82:581\u2013587. doi: 10.1136\/pgmj.2005.040857","journal-title":"Postgrad Med J"},{"key":"3344_CR34","unstructured":"Roser M (2016) Life Expectancy. http:\/\/ourworldindata.org\/data\/population-growth-vital-statistics\/life-expectancy\/ . Accessed 25 Mar 2016"},{"key":"3344_CR35","unstructured":"Cawthon LK (2006) Primate Factsheets: long-tailed macaque (Macaca fascicularis) Taxonomy, Morphology, & Ecology. < http:\/\/pin.primate.wisc.edu\/factsheets\/entry\/long-tailed_macaque >. Accessed 2016 March 21. Wisconsin Primate Research Center (WPRC) Library at the University of Wisconsin-Madison"},{"key":"3344_CR36","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.exer.2005.06.019","volume":"82","author":"L Jovanovik-Pandova","year":"2006","unstructured":"Jovanovik-Pandova L, Watson PG, Liu C, Chan WY, de Wolff-Rouendaal D, Barthen ER, Emmanouilidis-van der Spek K, Jager MJ (2006) Ciliary tissue transplantation in the rabbit. Exp Eye Res 82:247\u2013257. doi: 10.1016\/j.exer.2005.06.019","journal-title":"Exp Eye Res"},{"key":"3344_CR37","doi-asserted-by":"crossref","unstructured":"Schraermeyer U, Julien S (2012) Formation of immune complexes and thrombotic microangiopathy after intravitreal injection of bevacizumab in the primate eye. Graefe\u2019s archive for clinical and experimental ophthalmology. Graefes Arch Clin Exp Ophthalmol 250:1303\u20131313. doi: 10.1007\/s00417-012-2055-z","DOI":"10.1007\/s00417-012-2055-z"},{"key":"3344_CR38","doi-asserted-by":"crossref","first-page":"e100","DOI":"10.3928\/15428877-20111006-02","volume":"42","author":"JN Martel","year":"2011","unstructured":"Martel JN, Han Y, Lin SC (2011) Severe intraocular pressure fluctuation after intravitreal anti-vascular endothelial growth factor injection. Ophthalmic Surg Lasers Imaging : Off J Int Soc Imaging Eye 42:e100\u2013e102. doi: 10.3928\/15428877-20111006-02","journal-title":"Ophthalmic Surg Lasers Imaging : Off J Int Soc Imaging Eye"},{"key":"3344_CR39","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/jcu.20652","volume":"38","author":"A Mete","year":"2010","unstructured":"Mete A, Saygili O, Mete A, Bayram M, Bekir N (2010) Effects of intravitreal bevacizumab (Avastin) therapy on retrobulbar blood flow parameters in patients with neovascular age-related macular degeneration. J Clin Ultrasound 38:66\u201370. doi: 10.1002\/jcu.20650","journal-title":"J Clin Ultrasound"},{"key":"3344_CR40","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1056\/NEJMoa0707330","volume":"358","author":"V Eremina","year":"2008","unstructured":"Eremina V, Jefferson JA, Kowalewska J, Hochster H, Haas M, Weisstuch J, Richardson C, Kopp JB, Kabir MG, Backx PH, Gerber HP, Ferrara N, Barisoni L, Alpers CE, Quaggin SE (2008) VEGF inhibition and renal thrombotic microangiopathy. N Engl J Med 358:1129\u20131136. doi: 10.1056\/NEJMoa0707330","journal-title":"N Engl J Med"},{"key":"3344_CR41","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1084\/jem.20072041","volume":"205","author":"AS Maharaj","year":"2008","unstructured":"Maharaj AS, Walshe TE, Saint-Geniez M, Venkatesha S, Maldonado AE, Himes NC, Matharu KS, Karumanchi SA, D\u2019Amore PA (2008) VEGF and TGF-beta are required for the maintenance of the choroid plexus and ependyma. J Exp Med 205:491\u2013501. doi: 10.1084\/jem.20072041","journal-title":"J Exp Med"},{"key":"3344_CR42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0003554","volume":"3","author":"M Saint-Geniez","year":"2008","unstructured":"Saint-Geniez M, Maharaj AS, Walshe TE, Tucker BA, Sekiyama E, Kurihara T, Darland DC, Young MJ, D\u2019Amore PA (2008) Endogenous VEGF is required for visual function: evidence for a survival role on muller cells and photoreceptors. PLoS One 3, e3554. doi: 10.1371\/journal.pone.0003554","journal-title":"PLoS One"},{"key":"3344_CR43","doi-asserted-by":"crossref","first-page":"H560","DOI":"10.1152\/ajpheart.00133.2005","volume":"290","author":"T Kamba","year":"2006","unstructured":"Kamba T, Tam BY, Hashizume H, Haskell A, Sennino B, Mancuso MR, Norberg SM, O\u2019Brien SM, Davis RB, Gowen LC, Anderson KD, Thurston G, Joho S, Springer ML, Kuo CJ, McDonald DM (2006) VEGF-dependent plasticity of fenestrated capillaries in the normal adult microvasculature. Am J Physiol Heart Circ Physiol 290:H560\u2013576. doi: 10.1152\/ajpheart.00133.2005","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"3344_CR44","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0002-9394(70)91280-8","volume":"69","author":"M Yanoff","year":"1970","unstructured":"Yanoff M, Fine BS, Berkow JW (1970) Diabetic lacy vacuolation of iris pigment epithelium; a histopathologic report. Am J Ophthalmol 69:201\u2013210","journal-title":"Am J Ophthalmol"},{"key":"3344_CR45","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1136\/bjo.63.11.750","volume":"63","author":"R Fischer","year":"1979","unstructured":"Fischer R, Henkind P, Gartner S (1979) Microcysts of the human iris pigment epithelium. Br J Ophthalmol 63:750\u2013753","journal-title":"Br J Ophthalmol"},{"key":"3344_CR46","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s12325-010-0089-3","volume":"28","author":"AA Aref","year":"2011","unstructured":"Aref AA, Scott IU (2011) Management of macular edema secondary to branch retinal vein occlusion: an evidence-based update. Adv Ther 28:28\u201339. doi: 10.1007\/s12325-010-0089-3","journal-title":"Adv Ther"},{"key":"3344_CR47","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3341\/kjo.2014.28.1.19","volume":"28","author":"K Lee","year":"2014","unstructured":"Lee K, Jung H, Sohn J (2014) Comparison of injection of intravitreal drugs with standard care in macular edema secondary to branch retinal vein occlusion. Korean J Ophthalmol : KJO 28:19\u201325. doi: 10.3341\/kjo.2014.28.1.19","journal-title":"Korean J Ophthalmol : KJO"},{"key":"3344_CR48","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.ophtha.2013.11.041","volume":"121","author":"U Schmidt-Erfurth","year":"2014","unstructured":"Schmidt-Erfurth U, Lang GE, Holz FG, Schlingemann RO, Lanzetta P, Massin P, Gerstner O, Bouazza AS, Shen H, Osborne A, Mitchell P, Group RES (2014) Three-year outcomes of individualized ranibizumab treatment in patients with diabetic macular edema: the RESTORE extension study. Ophthalmology 121:1045\u20131053. doi: 10.1016\/j.ophtha.2013.11.041","journal-title":"Ophthalmology"},{"key":"3344_CR49","first-page":"591681","volume":"2013","author":"S Barge","year":"2013","unstructured":"Barge S, Rothwell R, Sepulveda P, Agrelos L (2013) Intravitreal and subtenon depot triamcinolone as treatment of retinitis pigmentosa associated cystoid macular edema. Case Rep Ophthalmol Med 2013:591681. doi: 10.1155\/2013\/591681","journal-title":"Case Rep Ophthalmol Med"},{"key":"3344_CR50","doi-asserted-by":"crossref","first-page":"487","DOI":"10.3109\/02713683.2013.763990","volume":"38","author":"Y Sugimoto","year":"2013","unstructured":"Sugimoto Y, Mochizuki H, Miyagi H, Kawamata S, Kiuchi Y (2013) Histological findings of uveal capillaries in rabbit eyes after multiple intravitreal injections of bevacizumab. Curr Eye Res 38:487\u2013496. doi: 10.3109\/02713683.2013.763990","journal-title":"Curr Eye Res"},{"key":"3344_CR51","first-page":"3393","volume":"35","author":"V Simorre-Pinatel","year":"1994","unstructured":"Simorre-Pinatel V, Guerrin M, Chollet P, Penary M, Clamens S, Malecaze F, Plouet J (1994) Vasculotropin-VEGF stimulates retinal capillary endothelial cells through an autocrine pathway. Invest Ophthalmol Vis Sci 35:3393\u20133400","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3344_CR52","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2353\/ajpath.2007.061237","volume":"171","author":"K Nishijima","year":"2007","unstructured":"Nishijima K, Ng YS, Zhong L, Bradley J, Schubert W, Jo N, Akita J, Samuelsson SJ, Robinson GS, Adamis AP, Shima DT (2007) Vascular endothelial growth factor-A is a survival factor for retinal neurons and a critical neuroprotectant during the adaptive response to ischemic injury. Am J Pathol 171:53\u201367. doi: 10.2353\/ajpath.2007.061237","journal-title":"Am J Pathol"},{"key":"3344_CR53","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1167\/iovs.09-4144","volume":"51","author":"SH Byeon","year":"2010","unstructured":"Byeon SH, Lee SC, Choi SH, Lee HK, Lee JH, Chu YK, Kwon OW (2010) Vascular endothelial growth factor as an autocrine survival factor for retinal pigment epithelial cells under oxidative stress via the VEGF-R2\/PI3K\/Akt. Invest Ophthalmol Vis Sci 51:1190\u20131197. doi: 10.1167\/iovs.09-4144","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3344_CR54","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.ajpath.2013.05.031","volume":"183","author":"N Beazley-Long","year":"2013","unstructured":"Beazley-Long N, Hua J, Jehle T, Hulse RP, Dersch R, Lehrling C, Bevan H, Qiu Y, Lagreze WA, Wynick D, Churchill AJ, Kehoe P, Harper SJ, Bates DO, Donaldson LF (2013) VEGF-A165b is an endogenous neuroprotective splice isoform of vascular endothelial growth factor A in vivo and in vitro. Am J Pathol 183:918\u2013929. doi: 10.1016\/j.ajpath.2013.05.031","journal-title":"Am J Pathol"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-016-3344-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00417-016-3344-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-016-3344-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,18]],"date-time":"2022-06-18T10:47:02Z","timestamp":1655549222000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00417-016-3344-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,22]]},"references-count":54,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["3344"],"URL":"https:\/\/doi.org\/10.1007\/s00417-016-3344-8","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,22]]}}}